RAMucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic colorectal cancer: Safety results from the phase IIb part of the RAMTAS phase II/III trial of the German AIO (AIO-KRK-0316).Stefan Kasper,Thorsten Oliver Goetze,Sebastian Stintzing,Ralf Dieter Hofheinz,Marianne Sinn,Tobias Nicolaas Dechow,Thomas Jens Ettrich,Verena Keitel,Ullrich Graeven,Ludwig Fischer von Weikersthal, Alexander Kolov,Thomas Edelmann,Alexander Stein,Tanja Trarbach, Sabine Junge,Claudia Pauligk,Isabel Virchow,Jens T. Siveke,Salah-Eddin Al-Batran,Martin H. SchulerJOURNAL OF CLINICAL ONCOLOGY（2021）引用 2|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
